DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Hopen Ls Manager II, LLC
Hopen Ls Manager II, LLC
venture manager, reported GAV $24.1M across 1 vehicles
Importance
7
low
Active deployment
0
low
Emerging
0
low
Completeness
38
elevated
Freshness
100
high
Research priority
2
low
Identity and regulatory footprint
- Headquarters
- Grand Rapids, MIadviserinfo.sec.gov
- Office address
- 171 MONROE AVENUE NW, SUITE 410, Grand Rapids, MI, 49503adviserinfo.sec.gov
- Business phone
- 616-325-2110adviserinfo.sec.gov
- Website
- HTTP://WWW.HOPENLS.COM
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Feb 1, 2016
- Private funds reported
- 1 (1 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $24.1Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Hopen Ls Management, LLC (Owner), E; Mark Olesnavage Trust (Owner), C
- business phone
- 616-325-2110adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
- Sectors
- not stated or not yet read
- Stages
- not stated or not yet read
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
1 reported, 1 no longer reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Hopen Life Science Fund II, L.P. | Fund | 2011 form d first sale | Harvest | $24.1M Feb 1, 2016 | 19 | $40.0M of $100M | Mar 5, 2013 |
| Hopen Life Sciences, LLC | Fund | unknown | Wound down | $18.6M Mar 6, 2013 | 4 | unknown | unknown |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
0 current, 0 departed
No named professional yet. People arrive from Form ADV Schedule A (owners, officers, control persons) and the team page.
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
4 dated events
- Mar 17, 2014Hopen Life Sciences, LLC no longer reported on Form ADV by Hopen Ls Manager II, LLCFund no longer reportedFundsInferenceHopen Life Sciences, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Hopen Ls Manager II, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Hopen Life Sciences, LLC first reported on Form ADV by Hopen Ls Manager II, LLC (Venture Capital Fund), GAV $21,656,176Fund first reported on Form ADVFundsFactHopen Life Sciences, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 30, 2012Hopen Life Science Fund II, L.P. first reported on Form ADV by Hopen Ls Manager II, LLC (Venture Capital Fund), GAV $3,879,415Fund first reported on Form ADVFundsFactHopen Life Science Fund II, L.P.SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 12, 2026Micro VC (confirmed, 95%, cls-1)venture manager, reported GAV $24.1M across 1 vehicles
Evidence
22 observations from 2 sources